Other Information
−Removed: | December 31, 2022, Form 10-Q
Exhibit Description
Amended and Restated Articles of Incorporation of the Registrant, as amended on August 1, 2012 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on August 6, 2012).
+Added: Articles of Amendment to the Company’s Amended and Restated Articles of Incorporation filed with the State Department of Assessments and Taxation of Maryland on March 7, 2023 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on March 21, 2023).
By-laws of the Registrant (incorporated by reference to Exhibit 3.2 to the Company’s Post-Effective Amendment No.1 to Form S-3 filed on January 22, 2021).
Amendment to the Amended and Restated Articles of Incorporation of the Registrant as amended on August 2, 2014 (incorporated by reference to Exhibit 3.3 to the Company’s Post-Effective Amendment No.1 to Form S-3 filed on January 22, 2021).
+Added: Amendment to the Bylaws of the Company dated March 2, 2023 (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed on March 21, 2023).
+Added: Employment Agreement, effective as of May 9, 2023, by and between IGC Pharma, Inc.
+Added: Claudia Grimaldi (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on May 5, 2023).
+Added: Form of Share Purchase Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on July 7, 2023).
+Added: Master Loan Agreement, dated June 30, 2023, between IGC Pharma, Inc.
+Added: and O-Bank, CO., LTD (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on July 7, 2023).
Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer.
10 unchanged sentences
Furnished herewith.
−Removed: | December 31, 2022, Form 10-Q
+Added: Management contract or compensatory plan or arrangement.
+Added: Certain schedules or similar attachments to this exhibit have been omitted in accordance with Item 601(a)(5) of Regulation S-K.
+Added: The registrant hereby agrees to furnish supplementally to the Securities and Exchange Commission upon request a copy of any omitted schedule or attachment to this exhibit.
+Added: | June 30, 2023, Form 10-Q
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: INDIA GLOBALIZATION CAPITAL, INC.
−Removed: February 14, 2023
+Added: IGC PHARMA, INC.
+Added: August 10, 2023
/s/ Ram Mukunda
1 unchanged sentence
(Principal Executive Officer)
−Removed: February 14, 2023
+Added: August 10, 2023
/s/ Claudia Grimaldi
Claudia Grimaldi
−Removed: Vice President
+Added: Vice-president & Chief Compliance Officer
(Principal Financial Officer)
−Removed: | December 31, 2022, Form 10-Q
+Added: | June 30, 2023, Form 10-Q
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.